Medicare Enrolled
Dr. Cesar Lassalle-Nieves, M.D.
Pain Medicine · Orlando, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lassalle-Nieves from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lassalle-Nieves?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lassalle-Nieves
Dr. Cesar Lassalle-Nieves is a pain medicine specialist in Orlando, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Lassalle-Nieves performed 700 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lassalle-Nieves received a total of $16,515 from 58 pharmaceutical and/or device companies across 836 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lassalle-Nieves is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ 700 Medicare services
$16,515 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗700
Medicare services
Bottom 37% in FL for pain medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
283 | $80 | $450 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
87 | $58 | $320 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
68 | $60 | $190 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
46 | $150 | $470 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
46 | $0 | $10 |
| Injection, methylprednisolone acetate, 40 mg | 37 | $6 | $20 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
36 | $126 | $580 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
26 | $195 | $600 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
22 | $10 | $50 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
19 | $59 | $339 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
16 | $100 | $512 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
14 | $77 | $340 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$16,515
Total received (2018-2024)
Avg $2,359/year across 7 years
Top 10% in FL for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
836
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,080
2023
$2,056
2022
$2,111
2021
$2,804
2020
$1,467
2019
$3,734
2018
$3,264
Payments by company (2024)
Boston Scientific Corporation
$324
Nevro Corp.
$255
Medtronic, Inc.
$124
Phadia US Inc.
$95
SCILEX PHARMACEUTICALS INC.
$70
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$65
Abbott Laboratories
$40
PROTEGA PHARMACEUTIALS INC
$39
IBSA Pharma Inc.
$24
Averitas Pharma Inc.
$21
Valinor Pharma, LLC
$17
Vertos Medical, Inc.
$7
Top 3 companies account for 65.2% of 2024 payments
All-time payments by company (2018-2024) ›
Nevro Corp.
$3,091
Abbott Laboratories
$2,800
Boston Scientific Corporation
$2,709
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,255
Medtronic USA, Inc.
$825
Medtronic, Inc.
$554
SCILEX PHARMACEUTICALS INC.
$490
Vertos Medical, Inc.
$483
BOSTON SCIENTIFIC CORPORATION
$398
ABBVIE INC.
$358
Scilex Pharmaceuticals Inc.
$292
PFIZER INC.
$284
Allergan Inc.
$266
Teva Pharmaceuticals USA, Inc.
$259
GRT US Holding, Inc.
$236
AbbVie Inc.
$163
Alkermes, Inc.
$125
Kowa Pharmaceuticals America, Inc.
$122
Amgen Inc.
$104
Camber Spine Technologies LLC
$104
Neurocrine Biosciences, Inc.
$101
Phadia US Inc.
$95
Stimwave Technologies Incorporated
$91
Orexo US, Inc.
$91
Novartis Pharmaceuticals Corporation
$87
Allergan, Inc.
$83
Daiichi Sankyo Inc.
$78
Flowonix Medical Incorporated
$77
Assertio Therapeutics, Inc.
$66
IBSA Pharma Inc.
$60
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$51
Almatica Pharma LLC
$46
Biohaven Pharmaceuticals, Inc.
$45
BioDelivery Sciences International, Inc.
$44
Spinal Simplicity, LLC
$41
PROTEGA PHARMACEUTIALS INC
$39
Nalu Medical, Inc.
$37
Lilly USA, LLC
$35
Hikma Pharmaceuticals USA
$33
Shionogi Inc
$29
Indivior Inc.
$28
Pernix Therapeutics Holdings, Inc.
$28
SI-BONE, Inc.
$28
Alnylam Pharmaceuticals Inc.
$28
Purdue Pharma L.P.
$27
RedHill Biopharma Inc.
$24
Collegium Pharmaceutical, Inc.
$22
Averitas Pharma Inc.
$21
DePuy Synthes Sales Inc.
$20
Masimo Corporation
$20
Bioventus LLC
$20
Janssen Pharmaceuticals, Inc
$19
Valinor Pharma, LLC
$17
Biogen, Inc.
$15
AstraZeneca Pharmaceuticals LP
$14
Currax Pharmaceuticals LLC
$14
Jazz Pharmaceuticals Inc.
$12
Kaleo, Inc.
$11
Top 3 companies account for 52.1% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · AXIUM · Aimovig · Axium INS DRG IPG · BELBUCA · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · CONTRAVE · Cambia · EMGALITY · ETERNA · Evzio · GENERAL - THERAPIES · GENERAL PAIN MANAGEMENT · GIVLAARI · GRALISE · General - Pain Management · HA MINUTEMAN G3-R · INGREZZA · INTELLIS · INTELLIS ADAPTIVESTIM · ImmunoCAP · Kloxxado · LUCEMYRA · LYRICA · Licart · MONOVISC · MOVANTIK · Morphabond ER · Movantik · NAPRELAN · NURTEC ODT · Nalu Neurostimulation System · Omnia · PROCLAIM · Patient SafetyNet System · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · Prometra II · QULIPTA · QUTENZA · Qutenza · RELISTOR · RELISTOR ORAL · RESTORE · REYVOW · ROXYBOND · SCS IPGs · SEGLENTIS · SPECTRA WAVEWRITER · SPECTRA WAVEWRITER (REFURBISHED) · SPINRAZA · SPRAVATO · SUBLOCADE · SYMPROIC · SYNCHROMED · Seglentis · Senza · Senza Spinal Cord Stimulation System · Stimrouter Implantable Kit · Symproic · Tirosint · UBRELVY · VIVITROL · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZAER · Xtampza ER · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zubsolv · iFuse Implant · mild Device Kit
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pain medicines in nearby ZIP areas
23
County median income
$77,011
Nearest hospital to ZIP centroid (approximate)
ADVENTHEALTH ORLANDO
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lassalle-Nieves is a clinical cardiology specialist, with moderate Medicare volume, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lassalle-Nieves experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lassalle-Nieves performed 283 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lassalle-Nieves receive payments from pharmaceutical companies?
Yes. Dr. Lassalle-Nieves received a total of $16,515 from 58 companies across 836 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lassalle-Nieves's costs compare to other pain medicines in Orlando?
Dr. Lassalle-Nieves's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lassalle-Nieves) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Orlando
Browse pain medicines in Orlando ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in FL
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in FL
Which FL pain medicines receive the most from drug and device companies.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology